Optinose (NASDAQ: OPTN) has announced plans to release its financial results for the fourth quarter and full year of 2024, ...

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to ...

At a meeting on Feb. 20, 2025, the board of directors at the Organ Procurement and Transportation Network (OPTN) declared Memorial Hermann Hospital, University of Texas at Houston, a member not in ...

Company to Host Conference Call Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m.

The national organ transplant system has leveled its most severe sanction against Memorial Hermann – Texas Medical Center following revelations that a liver transplant surgeon improperly manipulated ...

Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced preliminary ...

OptiNose (NASDAQ:OPTN – Get Free Report) is projected to release its earnings data before the market opens on Thursday, March 6th. Analysts expect OptiNose to post earnings of ($0.67 ...

2025 has already resulted in the termination of key personnel hired to implement OPTN modernization initiatives,” Wyden and Sanders wrote to Kennedy. With the rounds of terminations of workers ...

The designation means the OPTN member institution has "failed to comply with OPTN obligations." The OPTN oversees organ transplants in the U.S. The hospital is only the section to receive this ...

EST OptiNose (OPTN) trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...